RIGL

Rigel Pharmaceuticals Inc

• TipRanks·1d ago

  Analysts Are Bullish on These Healthcare Stocks: Rigel (RIGL), Opus Genetics (IRD)

• Seeking Alpha·08/19 08:14

  X4 Pharmaceuticals: Making Progress, But The Market Is Ahead Of The Trial (Rating Downgrade)

• Dow Jones·08/17 16:23

  Rigel Pharmaceuticals Is Maintained at Neutral by Piper Sandler

• Benzinga·08/17 16:13

  Piper Sandler Maintains Neutral on Rigel Pharmaceuticals, Raises Price Target to $49

• TipRanks·08/17 11:11

  Rigel Pharmaceuticals price target raised to $49 from $40 at Piper Sandler

• TipRanks·08/17 07:53

  Rigel Pharmaceuticals’ Veppanu available for metastatic breast cancer

• TipRanks·08/16 13:12

  Rigel Pharmaceuticals price target raised to $85 from $57 at H.C. Wainwright

• Dow Jones·08/14 17:47

  Rigel Pharmaceuticals Price Target Raised to $85.00/Share From $57.00 by HC Wainwright & Co.

• Dow Jones·08/14 17:47

  Rigel Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

• Benzinga·08/14 17:37

  HC Wainwright & Co. Maintains Buy on Rigel Pharmaceuticals, Raises Price Target to $85

• TipRanks·08/14 13:35

  H.C. Wainwright Reaffirms Their Buy Rating on Rigel (RIGL)

• Benzinga·08/13 12:13

  Rigel Pharmaceuticals' VEPPANU For Adults With Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative, Estrogen Receptor 1-Mutated Advanced Or Metastatic Breast Cancer Now Available Via U.S. Prescription

• TipRanks·08/06 10:21

  Rigel Pharmaceuticals price target raised to $83 from $81 at Citi

• TipRanks·08/06 10:10

  Analysts Offer Insights on Healthcare Companies: Arcus Biosciences (RCUS), Kymera Therapeutics (KYMR) and Rigel (RIGL)

• Simply Wall St·08/06 06:29

  Rigel Pharmaceuticals (RIGL) Stock Rally Runs Into Earnings Quality Doubts